Partner Andrew Wirmani was recently named on the 2025 Lawdragon 500 Leading Litigators in America list.
The list recognizes the most elite courtroom advocates in the U.S. across various practice areas, including commercial litigation, securities and corporate governance litigation, white collar and investigations, intellectual property and antitrust. Lawdragon recognized Wirmani for complex commercial litigation.
Wirmani’s recent complex commercial successes include favorably settling various class action lawsuits brought against DirectTV under the Telephone Consumer Protection Act and settling a $9 million fraud case brought against three healthcare companies by a national insurance carrier. He is currently defending a bank founder in a breach of fiduciary duty lawsuit alleging billions in damages.
Wirmani has also been instrumental to the firm’s recent plaintiff-side complex commercial wins – especially within RM’s False Claims Act/qui tam litigation practice. In 2024, he served a leading role on the Reese Marketos trial team that secured a $150 million jury verdict for two whistleblower clients against Johnson & Johnson subsidiary Janssen Products in a False Claims Act case. Earlier this year, that verdict grew to a record-breaking $1.64 billion judgment. Wirmani’s other recent False Claims Act wins for whistleblowers include a $100 million settlement with PharMerica Corp., a $36 million jury verdict against defense contractor MD Helicopters, and a $38.5 million settlement with Academy Mortgage Group.
As a former federal prosecutor, Wirmani’s practice also focuses on white collar defense. He is currently defending the CEO of one of the nation’s largest laboratories in parallel civil and criminal investigations brought by the Department of Justice. While an assistant U.S. Attorney in the Northern District of Texas, Wirmani led the investigation and two-month criminal trial of the Forest Park Medical Center case, which resulted in the imprisonment of several Dallas-area surgeons and is considered one of the largest and most complex healthcare prosecutions in Texas history.